Skip to main content

Xolair 150 mg/mL prefilled syringe Images

Generic Name: omalizumab

This medication has been identified as Xolair 150 mg/mL prefilled syringe. It is supplied by Genentech, Inc.

Xolair is used in the treatment of Urticaria; Nasal Polyps; Food Allergies; Asthma, Maintenance; Chronic Rhinosinusitis with Nasal Polyps and belongs to the drug class selective immunosuppressants. There is no proven risk in humans during pregnancy. Xolair 150 mg/mL prefilled syringe is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Xolair 150 mg/mL prefilled syringe medicine

Xolair

Generic Name
omalizumab
Strength
150 mg/mL prefilled syringe
Availability
Prescription only
Drug Class
Selective immunosuppressants
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Genentech, Inc.
National Drug Code (NDC)
50242-0215

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.